Novartis Campus
Forum 1
4056
Basel
Switzerland

 www.nibr.com

Participant's Lead

Cristina Lopez-Lopez Translational Medicine Expert, Neuroscience Discovery, Novartis Institutes for BioMedical Research  Contact

Institute Presentation

Novartis will partner in WP03 proving its expertise in clinical trials and  supplementing with  the placebo arm  of a Novartis development trial of a new compound with a CIAS target to examine the comparability and validity of CogState against the MCCB “standard” .
Novartis will partner in WP05 providing expertise in neuroimaging biomarkers, specifically receptor occupancy molecular imaging. Novartis will also monitor the project for opportunities to contribute technologies and tools to later stages of the program as it evolves to meet the central aims of the WP.